“Vaccine production in the country is also dependent on raw material from other countries hence there is a need for a major push on active pharmaceutical ingredients (API) to be produced in the country,” Saraswat, Chairman-TIFAC Governing Council and Member NITI Aayog, said.

India reaches out to US companies over investment in pharmaceutical, medical devices sector. India’s Ambassador to the US Taranjit Singh Sandhu has held virtual meetings with Alberta Bourla, the CEO of Pfizer, Thermo Fisher CEO Marc Casper, Bernd Brust, the chairman and CEO of Antylia Scientific, and Joseph Repp, the CEO of Pall Life Sciences.

India’s New Unicorn Is EPharmacy API Holdings Pvt will use funds to expand its network and add more tele-consultations to link up customers with the 60,000 brick-and-mortar pharmacies and 4,000 doctors it already has on its books.